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The thiopurines, 6-thioguanine and Results and discussion
4-thiothymidine incorporation into DNA6-mercaptopurine, are antileukemic agents that are
and lack of toxicityincorporated into DNA following retrieval by the
SV40-transformed MRC5VA normal fibroblasts, the Rajipurine salvage pathway (see [1] for a review). Their
Burkitt’s lymphoma, XP12RO complementation group Atoxicity requires active DNA mismatch repair
xeroderma pigmentosum fibroblasts, and an MMR-defec-(MMR), and thiopurine resistance is an
tive derivative of XP12RO (XP12ROB4, which is defi-acknowledged phenotype of MMR-defective cells
cient in the hMSH2 mismatch recognition factor [5]) all[2, 3]. In addition to these direct cytotoxic effects,
incorporated 4-thiothymidine (S4TdR, Figure 1a) intoDNA thiobases have distinctive photochemical
DNA. Substitution of the thymine 4-oxygen with sulfurproperties [4], the therapeutic potential of which has
shifts the absorption spectrum toward longer wavelengths,not been extensively evaluated. We report here
and S4TdR absorbs maximally at 335 nm (Figure 1a). Thisthat the thiopyrimidine nucleoside 4-thiothymidine
property was exploited to detect the thionucleoside inis incorporated into DNA. It does not induce MMR-
HPLC eluates of enzymatically digested DNA. Afterrelated toxicity, but it interacts synergistically with
growth in 100 M S4TdR, the thionucleoside was presentUVA light and dramatically sensitizes cultured
in cellular DNA. Approximately 0.5% (mean of four deter-human cells to very low, nonlethal UVA doses.
minations; range, 0.2%–1.3%) of DNA thymidine (TdR)4-thiothymidine induced UVA dose enhancements of
was replaced by S4TdR. An example of DNA fromaround 100-fold in DNA repair-proficient cells.
MRC5VA cells is shown in Figure 1c. Assays with cellNucleotide excision repair-defective xeroderma
extracts confirmed that S4TdR was a substrate for thymi-pigmentosum cells were sensitized up to 1000-fold,
dine kinase (TK), which is the first step in thymidineimplicating bulky DNA photoproducts in the lethal
salvage (also see [6]). It was not a substrate for thymidineeffect. The synergistic action of thiothymidine plus
phosphorylase, which degrades thymidine and reduces itsUVA required thymidine kinase, indicating a
availability for incorporation into DNA (data not shown).selective toxicity toward rapidly proliferating cells.
These findings are consistent with the incorporation ofCooperative UVA cytotoxicity is a general property
S4TdR into DNA mediated by the thymidine salvageof DNA thiobases, and 6-thioguanine and
pathway. Replacement of about 0.5% of DNA TdR by4-thiodeoxyuridine were also UVA sensitizers.
the thiodeoxynucleoside compares well with the 1%–3%Thiobase/UVA treatment may offer a novel
substitution of guanine by 6-thioguanine (S6G) aftertherapeutic approach for the clinical management
growth in highly cytotoxic (1% survival) concentrationsof nonmalignant conditions like psoriasis or for
of the thiopurine [2].superficial tumors that are accessible to
phototherapy.
S4TdR was not detectably toxic. Raji cells proliferated atAddresses: * Imperial Cancer Research Fund, Clare Hall Laboratories,
comparable rates in medium supplemented with eitherSouth Mimms, Herts. EN6 3LD, United Kingdom. † Department of
Biochemistry and Molecular Biology, University College London, S4TdR or TdR at concentrations up to 300 M. A typical
Gower Street, London WC1E 6BT, United Kingdom. growth curve is shown in Figure 2. A concentration of S6G
(1 M) that produces similar levels of DNA substitutionCorrespondence: Peter Karran
induced irreversible growth arrest and death in the sameE-mail: karran@icrf.icnet.uk
cells (Figure 2). There was no evidence of S4TdR toxicity
‡ Present address: Department of Chemistry, The Open University, in several other cell lines, including MRC5VA and
Walton Hall, Milton Keynes MK7 6AA, United Kingdom. XP12RO, the A2780 ovarian carcinoma and its MMR-
deficient variant A2780MNU1 [7], and the MMR-defec-Received: 23 April 2001
tive HCT116 colon carcinoma. All of these cells prolifer-Revised: 17 May 2001
Accepted: 18 May 2001 ated normally in the presence of 100 Mor greater S4TdR
(data not shown). Growth in S4TdR was not highly muta-
Published: 24 July 2001
genic. S4TdR (100 M) increased the frequency of muta-
tion in the adenine phosphoribosytransferase gene ofCurrent Biology 2001, 11:1142–1146
CHO cells from 3.5  105 to 5.1  105 per cell (means
0960-9822/01/$ – see front matter of three independent experiments), an increase of only
 2001 Elsevier Science Ltd. All rights reserved.
1.5-fold. Thus, despite significant incorporation into cel-
lular DNA, S4TdR is neither cytotoxic nor highly muta-
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Figure 1 not share the well-documented MMR-dependent lethal-
ity of DNA S6G.
Synergistic toxicity of UVA and 4-thiothymidine
Although it was not directly toxic, growth for several days
in S4TdR sensitized cells to a subsequent exposure to
UVA light. At 100 M S4TdR, the D37 value for UVA
(  320–400nm) of MRC5VA fibroblasts was 1 kJ/m2
(Figure 3a). Survival of the same cells grown in the ab-
sence of S4TdRwas not detectably affected byUVA doses
below 10 kJ/m2, and their D37 of 70 kJ/m2 (data not shown)
was comparable to published estimates for cultured nor-
mal human fibroblasts [9, 10]. The photosensitizing effect
of S4TdRwas dose-dependent, and increasing UVA sensi-
tivity was observed between 1Mand 300Mnucleoside
(Figure 3a). At the highest S4TdR concentration, the D37
for UVA was reduced to 0.5 kJ/m2, which represents a
sensitization factor of 100-fold.
The cytotoxicity of S4TdR/UVA depends on active pyrim-
idine nucleoside salvage. Raji cells grown in 100 M
S4TdR and exposed to 8 kJ/m2 UVA underwent growth
arrest and cell death. In contrast, the TK Raji variant
that was treated under identical conditions proliferated
for7 days at a rate indistinguishable from that of unirra-
diated control cells. As expected, neither Raji variant was
affected by growth in S4TdR or by 8 kJ/m2 UVA alone
(Figure 3b and data not shown). TK is a marker of active
cell proliferation, and S4TdR/UVA therefore mediates a
selective killing of actively proliferating cells.
The lethal effect of S4TdR depends on photoinduced
DNA damage. Three nucleotide excision repair-deficient
cell lines, XP12RO and GM04429F (both xeroderma pig-
mentosum complementation group A) and GM08437B
(complementation group F), were markedly more sensi-
tive to S4TdR plus UVA than NER-proficient MRC5VA
cells (Figure 3c). After growth in 100 M S4TdR, the D37
value for XP12RO was 0.04 kJ/m2. For GM04429F and
Structure and absorption spectra of (a) 4-thiothymidine and (b) GM08437B, this value was 0.07 kJ/m2. XPA cells were
6-thioguanine. (c) HPLC detection of S4TdR incorporated into cellular somewhat more sensitive thanNER-proficient fibroblastsDNA. MRC5VA cells were grown for 3 days in medium containing
to UVA alone, and the D37 value for XP12RO was25 kJ/extensively dialyzed fetal calf serum at a final concentration of 10%
and 100 M S4TdR. Cells proliferated at normal rates during this m2. (UVA alone was not detectably toxic to XP fibroblasts
treatment. Cells were harvested, and DNA was extracted and below 5 kJ/m2. This dose is 50-fold higher than the maxi-
extensively washed and digested to nucleosides, which were mumdose used in combinationwith S4TdR).NER-defec-separated by reverse phase HPLC as described [21]. The absorbance
tive cells are therefore about 10-fold more sensitive to theof the eluate was monitored simultaneously at 260 nm (upper trace,
solid line) and 335 nm (lower trace, dotted line). 4-thiothymidine combined effects of S4TdR and UVA than NER-proficient
(S4TdR) elutes at 22 min. The elution positions cells grown under identical conditions. UVA dose enhance-
of the major deoxynucleosides are indicated. ments approaching 1000-fold can be achieved in NER-
deficient XP cells by growth in nontoxic concentrations of
S4TdR.
genic. The thiopyrimidine resembles thioguanine in its
inability to induce a significant increase in mutation; the UVA-induced toxicity of other thiobases
Other thiobases, including S6G (Figure 1b), also absorb inthiopurine is also a poor mutagen [8]. The similar mutage-
nicity of S4TdR and S6G contrasts markedly with their the UVA region and act as UVA photosensitizers. Because
MMR-defective cells incorporate S6G into DNA withoutvery different cytotoxic effects. In particular, S4TdR does
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Figure 2
S4TdR is nontoxic to growing cells.
Exponentially growing cultures of Raji cells
in medium containing 10% dialyzed fetal calf
serum were supplemented with either 100
M S4TdR (solid circle), 100 M TdR (open
circle), 1 M S6G (solid triangle), or no
additions (open triangle). Cell growth was
monitored by daily hemocytometer counts.
detriment, we used XP12ROB4, the hMSH2-defective reduced capacity to excise DNA-protein crosslinks. Alter-
natively, the potentially lethal damage may be photo-variant of XP12RO, to investigate the phototoxicity of
DNA S6G. The growth of XP12ROB4 cells is unaffected chemically induced intrastrand DNA lesions. UVA in-
duces preferential crosslinking of DNA S4TdR to a 5by S6G concentrations up to 5 M [5]. The UVA sensitiv-
ity of XP12ROB4 is comparable to the parent XP12RO thymine [4, 16]. The resulting dipyrimidine (6,4) pho-
toproducts resemble the pyrimidine-pyrimidone (6,4)(data not shown). After culture for three days in 3 M
S6G, significant toxicity was induced by UVA doses of DNA adducts that are produced by UVC and to which
XP cells are sensitive [17]. In preliminary experiments,0.02 kJ/m2 (Figure 3d), and the D37 value was reduced
from 25 kJ/m2 to 0.1 kJ/m2, a sensitization factor of 250- we observed that S4TdR/UVA resistance is restored to
almost wild-type levels in the XP129 “revertant” offold. Thus, in addition to its direct, MMR-related toxicity,
DNA S6G is also a photosensitizer for UVA. The syner- XP12RO. Although these cells have a complex pheno-
type, they are acknowledged to have regained UVC resis-gistic cytotoxicity of S6G plus UVA was also observed in
a second MMR-defective cell line, HeLa Clone 7, that tance together with the ability to excise UVC-induced
pyrimidine-pyrimidone (6,4) DNA adducts [18]. Thedoes not express the hPMS2 MMR protein [11] (data not
shown). S4TdR/UVA resistance of XP129 cells is consistent with
a significant contribution of (6,4) photoadducts to S4TdR/
UVA-induced cell death. A better understanding of theUVA also exhibited synergistic toxicity with 4-thiodeoxy-
precise mechanism of toxicity awaits more direct chemicaluridine (S4UdR) in XP12RO cells, although the effect was
quantitation of S4TdR/UVA DNA photoproducts and anmoremodest. A nontoxic concentration (100 M) reduced
analysis of the sensitivity of cells with more subtle NERtheirD37 value from25 kJ/m2 to1 kJ/m2 (data not shown).
defects such as those derived from individuals affectedAfter phosphorylation, S4UdR enters the de novo pathway
by XPC, Cockayne’s syndrome, or trichothiodystrophyof pyrimidine deoxynucleoside synthesis at the thymidy-
[17]. Whether UVA induces repairable DNA lesions atlate synthetase step. Discrimination against the thio-
S6G bases is unclear, although irradiation of 5 thymidyl-nucleoside at either the phosphorylation or methylation
S6 deoxyinosine produces a purine-pyrimidine (6,6) ad-step may limit its effectiveness [12]. S4UdR is neverthe-
duct that is analogous to the (6,4) dipyrimidine prod-less still capable of significant cooperative cytotoxicity
uct [19].with UVA.
Cytotoxic mechanism and therapeutic implications DNA thiobases clearly induce a remarkable degree of
cellular sensitization to UVA, a relatively innocuous typeIn summary, thiobases combine with nonlethal doses of
UVA light to produce a truly cooperative cytotoxicity in of radiation. Might it be possible to exploit this property
clinically? S6G, mercaptopurine, or the immunosuppres-cultured human cells. This selective cell killing has not
been previously reported, although S4TdR plus UVA has sant prodrug azathioprine all induce considerable thiopur-
ine substitution of DNA. DNA S6G itself is relativelya modest antiviral effect [13]. The extreme sensitivity of
xeroderma pigmentosum cells to S4TdR/UVA implicates harmless, its MMR-dependent cytotoxicity arises from
the very few (about one in 105) bases that undergo S-meth-bulkyDNAdamage in the cytotoxicity. UVA irradiation of
DNA thiobases promotes their reaction with nucleophilic ylation [3]. Thus, even in MMR-proficient cells, subtoxic
drug concentrations might provide sufficient DNA thio-groups of proteins [14] or neighboring DNA constituents
[15]. Thus, the hypersensitivity of XP cells may reflect a purines to interact lethally with nontoxic doses of UVA.
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Figure 3
(a) Synergistic toxicity of S4TdR and UVA in
MRC5VA fibroblasts. Exponentially growing
MRC5VA cells were grown for 3 days in
medium containing 10% dialyzed fetal calf
serum and the concentration of S4TdR
indicated. Cells were washed, trypsinized,
and replated in fresh growth medium without
added nucleoside. They were allowed to
attach for 4 hr. Attached cells were irradiated
under a thin layer (1 mm) of PBSA with a
UVH 253 UVA lamp (UV Light Technology,
wavelength range 320–400, max  365nm)
as shown. The maximum dose rate of 100 J/
s/m2 was calibrated using a UV-A meter (UV
Light Technology). After radiation,
unsupplemented normal growth medium was
replaced. Surviving colonies were stained and
scored after 10 days. Sensitivity was
assessed by D37 values, and sensitization
factors are expressed as the ratio of D37
values (usually without:with S4TdR). (b)
Dependence of S4TdR/UVA cytotoxicity on
active thymidine kinase. Raji Burkitt’s
lymphoma cells (upper panel) or the TK
variant (lower panel) were cultured for 3 days
in medium containing 100 M S4TdR. After
washing, cells were divided into two separate
cultures, one of which (open square, open
triangle) was irradiated as a thin layer in
suspension in PBSA with 8 kJ/m2 UVA. The
second culture (solid square, solid triangle)
was unirradiated. Cells were returned to full
growth medium without S4TdR and counted
daily using a hemocytotmeter. (c) Sensitivity
of XP fibroblasts to S4TdR/UVA. XP12RO
(open circle), GM04429F (open square), and
GM08437B (solid square) were grown for 3
days in medium containing 10% dialyzed
fetal calf serum and 100 M S4TdR. They were
UVA irradiated at a dose rate of 2 J/s/m2 to
the final doses shown, and survival was
determined as described above. (d) The
sensitivity of XP12ROB4 cells to S6G/UVA.
Mismatch repair-defective XP12ROB4 cells
were grown for 3 days in medium
supplemented (open triangle), or not (solid
triangle), with a nontoxic concentration (3 M)
of S6G. Cells were harvested and irradiated,
and survival was determined as described
above.
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